FATE
Fate Therapeutics Inc
2.50$
+0.0%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 817.0% | 600.9% | 836.8% | 1,181.9% | 821.8% | 399.6% | 10.5% | 14.3% | 247.4% | 869.6% | 194.1% | |
| – | -717.0% | -500.9% | -736.8% | -1,081.9% | 100.0% | -299.6% | 89.5% | 100.0% | -147.4% | -769.6% | -94.1% | |
| – | 817.0% | 600.9% | 836.8% | 1,181.9% | 821.8% | 399.6% | 385.9% | 332.8% | 271.7% | 990.4% | 1,622.5% | |
| – | 425.8% | 225.2% | 289.2% | 333.5% | 221.3% | 107.8% | 102.6% | 87.5% | 128.2% | 544.1% | 700.0% | |
| – | 1,242.8% | 826.1% | 1,125.9% | 1,515.4% | 1,043.1% | 107.8% | 478.1% | 420.2% | 152.5% | 773.1% | 2,128.3% | |
| – | -1,142.8% | -726.1% | -1,025.9% | -1,415.4% | -943.1% | -407.5% | -388.6% | -320.2% | -299.9% | -1,542.6% | -2,222.4% | |
| – | 91.3% | 37.2% | 30.9% | 35.8% | 16.4% | 7.6% | 8.1% | 6.1% | – | – | – | |
| – | -1,233.7% | -760.2% | -1,046.1% | -1,405.0% | -919.0% | -551.6% | -379.9% | -292.5% | -253.3% | -1,366.5% | -2,051.1% | |
| – | -27.8% | -16.9% | 7.2% | 46.2% | -4.1% | -9.8% | -10.5% | -27.7% | 28.5% | – | – | |
| – | -1,233.7% | -760.2% | -1,046.1% | -1,405.0% | -919.0% | -551.6% | -379.9% | -264.9% | -253.3% | -1,366.5% | -2,051.1% | |
| – | -1,114.2% | -703.0% | -991.5% | -1,343.8% | -882.1% | -397.7% | -369.4% | -305.9% | -224.5% | -1,295.4% | -1,911.2% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.